Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Pieter G. M. van Gageldonk"'
Autor:
Evi van Schuppen, Janeri Fröberg, Prashanna Balaji Venkatasubramanian, Pauline Versteegen, Hans de Graaf, Jana Holubová, Joshua Gillard, Pieter G. M. van Gageldonk, Irma Joosten, Ronald de Groot, Peter Šebo, Guy A. M. Berbers, Robert C. Read, Martijn A. Huynen, Marien I. de Jonge, Dimitri A. Diavatopoulos
Publikováno v:
Nature Communications, Vol 13, Iss 1, Pp 1-11 (2022)
Bordetella pertussis (Bp), the causative agent of pertussis, continues to circulate and it’s not well understood how (sub)clinical infections shape immune memory to Bp and vaccination. Here, using a mutant Bp strain lacking antigens of the acellula
Externí odkaz:
https://doaj.org/article/89b65445de2a46a88e026c42b7c1a8cc
Autor:
Rutger M. Schepp, Joanna Kaczorowska, Pieter G. M. van Gageldonk, Elsbeth D. M. Rouers, Elisabeth A. M. Sanders, Patricia C. J. Bruijning-Verhagen, Guy A. M. Berbers
Publikováno v:
Vaccines, Vol 11, Iss 12, p 1807 (2023)
Respiratory Syncytial Virus (RSV) poses a severe threat to infants, particularly preterm infants. Palivizumab, the standard preventive prophylaxis, is primarily utilized in high-risk newborns due to its cost. This study assessed palivizumab’s effec
Externí odkaz:
https://doaj.org/article/6e6ad2c1ba0a4307a1be5aafdc967748
Autor:
Joshua Gillard, Bastiaan A. Blok, Daniel R. Garza, Prashanna Balaji Venkatasubramanian, Elles Simonetti, Marc J. Eleveld, Guy A. M. Berbers, Pieter G. M. van Gageldonk, Irma Joosten, Ronald de Groot, L. Charlotte J. de Bree, Reinout van Crevel, Marien I. de Jonge, Martijn A. Huynen, Mihai G. Netea, Dimitri A. Diavatopoulos
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-9 (2022)
Abstract Acellular pertussis (aP) booster vaccines are central to pertussis immunization programs, although their effectiveness varies. The Bacille Calmette-Guérin (BCG) vaccine is a prototype inducer of trained immunity, which enhances immune respo
Externí odkaz:
https://doaj.org/article/03fd26af521743d3bf22ca86c1c84e94
Autor:
Pauline Versteegen, Axel A. Bonačić Marinović, Pieter G. M. van Gageldonk, Saskia van der Lee, Lotte H. Hendrikx, Elisabeth A. M. Sanders, Guy A. M. Berbers, Anne-Marie Buisman
Publikováno v:
Vaccines, Vol 10, Iss 5, p 693 (2022)
Booster vaccinations for pertussis are advised in many countries during childhood or adulthood. In a phase IV longitudinal interventional study, we assessed long-term immunity following an extra pertussis booster vaccination in children and adults. C
Externí odkaz:
https://doaj.org/article/32ce92dc62c0403bbfc7ec9f0025313a
Autor:
Saskia van der Lee, Debbie M. van Rooijen, Mary-Lène de Zeeuw-Brouwer, Marjan J. M. Bogaard, Pieter G. M. van Gageldonk, Axel Bonacic Marinovic, Elisabeth A. M. Sanders, Guy A. M. Berbers, Anne-Marie Buisman
Publikováno v:
Frontiers in Immunology, Vol 9 (2018)
IntroductionTo reduce the pertussis disease burden, nowadays several countries recommend acellular pertussis (aP) booster vaccinations for adults. We aimed to evaluate the immunogenicity of a first adult aP booster vaccination at childbearing age.Met
Externí odkaz:
https://doaj.org/article/641f30a416294ff1bf277e8dd9f485a5
Autor:
Joshua, Gillard, Bastiaan A, Blok, Daniel R, Garza, Prashanna Balaji, Venkatasubramanian, Elles, Simonetti, Marc J, Eleveld, Guy A M, Berbers, Pieter G M, van Gageldonk, Irma, Joosten, Ronald, de Groot, L Charlotte J, de Bree, Reinout, van Crevel, Marien I, de Jonge, Martijn A, Huynen, Mihai G, Netea, Dimitri A, Diavatopoulos
Publikováno v:
NPJ vaccines. 7(1)
Acellular pertussis (aP) booster vaccines are central to pertussis immunization programs, although their effectiveness varies. The Bacille Calmette-Guérin (BCG) vaccine is a prototype inducer of trained immunity, which enhances immune responses to s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ff40c821cb5617cd30cec15001441146
https://pubmed.ncbi.nlm.nih.gov/35177621
https://pubmed.ncbi.nlm.nih.gov/35177621
Autor:
Jan van de Kassteele, Ronald de Groot, Jussi Mertsola, Pieter G. M. van Gageldonk, Dominic F. Kelly, Dimitri A. Diavatopoulos, Guy A. M. Berbers, Raakel Luoto, Qiushui He, S Bibi, Anne-Marie Buisman, Alex M. Barkoff, Elisabeth A. M. Sanders, Marlies A. van Houten, Pauline Versteegen, Marta Valente Pinto
Publikováno v:
EBioMedicine, Vol 65, Iss, Pp 103247-(2021)
EBioMedicine
Ebiomedicine, 65
eBioMedicine
EBioMedicine
Ebiomedicine, 65
eBioMedicine
Background Pertussis can lead to serious disease and even death in infants. Older adults are more vulnerable to complications as well. In high-income countries, acellular pertussis vaccines are used for priming vaccination. In the administration of b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0067d773140c2cf0b09b930b836387b0
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/234064
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/234064
Autor:
Alex M. Barkoff, Dominic F. Kelly, Marlies A. van Houten, Marta Valente Pinto, Pauline Versteegen, Anne-Marie Buisman, Raakel Luoto, Guy A. M. Berbers, Jan van de Kassteele, Jussi Mertsola, Elisabeth A. M. Sanders, Pieter G. M. van Gageldonk, Qiushui He, S Bibi
Publikováno v:
SSRN Electronic Journal.
Background: Pertussis can lead to serious disease and even death in infants. In addition older adults and patients with chronic diseases are more vulnerable to complications. In high-income countries, priming vaccination in infancy is usually underta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e6e8c927cbd590e2c0e25aac4d250618
https://doi.org/10.2139/ssrn.3708334
https://doi.org/10.2139/ssrn.3708334
Autor:
Guy A. M. Berbers, Pieter G. M. van Gageldonk, Josephine A.P. van Dongen, Elsbeth D M Rouers, Patricia Bruijning-Verhagen, Elisabeth A. M. Sanders
Publikováno v:
JAMA
IMPORTANCE: The standard schedule of national immunization programs for infants may not be sufficient to protect extremely and very preterm infants. OBJECTIVE: To evaluate the immunogenicity of routine vaccinations administered to preterm infants. DE
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab5653a94712b5e26eb484434eed7b46
https://doi.org/10.1001/jama.2020.12316
https://doi.org/10.1001/jama.2020.12316
Autor:
Saskia, van der Lee, Susanne P, Stoof, Mariette B, van Ravenhorst, Pieter G M, van Gageldonk, Nicoline A T, van der Maas, Elisabeth A M, Sanders, Anne-Marie, Buisman, Guy A M, Berbers
Publikováno v:
Eurosurveillance
Introduction In 2012 a large epidemic of pertussis occurred in the Netherlands. We assessed pertussis toxin (PT) antibody levels in longitudinal serum samples from Dutch 10–18 year-olds, encompassing the epidemic, to investigate pertussis infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::94eef352f7f26b2effce5a3867b234fb
https://pubmed.ncbi.nlm.nih.gov/29183555
https://pubmed.ncbi.nlm.nih.gov/29183555